News Archive

Noteworthy: Research grants, awards and publications
The latest developments on University at Albany faculty and staff who are receiving research grants, awards and other noteworthy attention.

UAlbany Researchers Unlock New Capabilities in DNA Nanostructure Self-assembly
RNA Institute scientists are pioneering new methods for designing and assembling DNA nanostructures, enhancing their potential for applications in medicine, materials science and data storage

Halvorsen Lab Spotlight with Research Support Specialist Dadrian Cole '23
UAlbany's Dadrian Cole '23 decided to continue her work in the Halvorsen lab between completing undergrad and preparing for medical school. Learn about Dadrian's work with nanostructures, her latest publication in Nano Letters and insights on the intersection of nanoscience and medicine.

NIH-Funded Cancer Drug Delivery Platform Continues Through Clinical Trials
UAlbany chemist Max Royzen, in collaboration with San Francisco-based biotech company Shasqi, is developing an innovative drug delivery platform to fight cancer. As the platform evolves, the team is actively honing ways to improve delivery modes to enhance drug efficacy and patient experience.

Podcast: Director Andy Berglund talks on "Chat with Pat"
RNA Institute Director Andy Berglund talks with State Senator Pat Fahy on her podcast show "Chat with Pat" on recent changes in higher education, funding freeze, etc.

Chemist Receives $1.95M for Research on AI-Powered Pathogen Detection, Precision Therapeutics
Mehmet Yigit has received $1.95 million from the National Institute of General Medical Sciences to advance his transdisciplinary research program focused on AI-powered biosensing and precision therapeutics.

Celebrating 10 Years at the ‘Interface of Science and Engineering’
The 2025 installment of the ‘Life at the Interface of Science and Engineering’ endowed lecture series will examine the convergence of medical, physical and engineering sciences, empowered by AI.

Biology Graduate Student Contributes to Research in Neurodegenerative Disease
Graduate student Asmer Aliyeva is working to reveal the molecular mechanisms behind neurodegenerative diseases, with a focus on spinocerebellar ataxias. With colleagues in the Berglund Lab, Aliyeva hopes to identify possible therapeutic targets against this class of disease.